Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor.

Jiayu Ling,Lishuo Shi,Xingyu Cheng,Yang Fu, Ziqin Lin,Yandong Zhao, Zheqing Li,Jianwei Zhang,Huabin Hu,Yue Cai,Yanhong Deng

Journal of gastrointestinal oncology（2023）

Cited 0|Views26
No score
Abstract
When compared to UR + AT, NAT + resection + AT may reduce the risk of distant recurrence in localized GIST and may be especially beneficial for patients with non-gastric GISTs.
More
Translated text
Key words
Gastrointestinal stromal tumors,imatinib mesylate,neoadjuvant therapy,retrospective studies,treatment outcome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined